Skip to main content

Weather Alert

Hurricane activity is severely impacting Quest locations across the Southeast. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational.

Hide
Quest Diagnostics

Genetic Testing for ANO5 in Over 1,300 Patients

2023 National Society of Genetic Counselors (NSGC) Conference

NSGC 2023

Chicago, IL, October 17-21, 2023

Poster presentation: Genetic testing for ANO5 in over 1,300 patients

Authors: Powis Z, Meservey M, Liaquat K, Lutz J, Batish SD

Specialty: Genetics, Neurology

Related content

Conference Presentation
Not Presymptomatic: Genetic Testing for Spinocerebellar Ataxia Type 10 in Over 2,300 Patients Younger Than 12
Publication
Impact of a Digital Diabetes Prevention Program on Risk factors for Chronic Disease in a Workforce Cohort
Publication
Perceived Barriers, Recommendations, and Resources for Multistate Licensure in the United States: A Mixed-Methods Study of Laboratory Genetic Counselors

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.